Social networks
295 615Activities
Technologies
Entity types
Location
3 Babbage Way, Exeter EX5 2FN, UK
Exeter
United Kingdom
Employees
Scale: 2-10
Estimated: 17
Engaged corporates
9Added in Motherbase
1 year, 3 months agoAward-winning company empowering patients through gold-standard rapid diagnostics
Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been awarded grants for research from the UK Government due to the importance of its work.
Attomarker works in the personalised medicine market and is committed to providing gold-standard rapid diagnostics to enable better and more timely decisions about health and health interventions.
It has a significant pipeline of tests but is currently focused on four of the most important global health challenges: COVID-19, Obesity, Food Allergy and Antimicrobial Resistance (AMR).
The company developed a technology for measuring multiple biomarkers in blood and saliva to provide a personal profile for up to 20 tests in 7 minutes. The data can be used by patients to make more informed decisions about their health, wellbeing and protection, and by healthcare professionals to determine a personalised patient healthcare pathway across multiple healthcare settings at the bedside, in the operating theatre, in the pharmacy and at home.
Currently the Company’s products are available in the UK, Cayman Islands and Malta, with plans to roll out on a more global footing in the year ahead. It’s an exciting time for Attomarker but perhaps even more so for the patients served by its innovative gold-based nanophotonic technology.
If you wish to find out more about our technology please visit our website www.attomarker.com or contact us directly via email at info@attomarker.com
Healthcare Diagnostics, Patient monitoring, Digital Health, Biomarker Innovation, POC Diagnostics, Biotechnology, MedTech, Consumer Health Technology, and Blood Testing Technology
Attomarker constantly innovates and delivers Gold Standard Rapid Diagnostics at the point-of-care. Attomarkerbelieves that new challenges to our health require innovative answers inspired by rigorous science.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
NHS England Insurance, Hospitals and Health Care | NHS England Insurance, Hospitals and Health Care | Other 3 Apr 2024 | | |
UK Export Finance National and local authorities, Financial Services | UK Export Finance National and local authorities, Financial Services | Other 3 Apr 2024 | | |
UK Atomic Energy Authority Research, National and local authorities | UK Atomic Energy Authority Research, National and local authorities | Other 3 Apr 2024 | | |
Prime Time Healthcare Startup accelerator & VC, Publishing, Hospitals and Health Care | Prime Time Healthcare Startup accelerator & VC, Publishing, Hospitals and Health Care | Other 12 Jan 2024 | | |
Elsevier Publishing, IT Services and IT Consulting | Elsevier Publishing, IT Services and IT Consulting | Other 21 Mar 2023 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 21 Mar 2023 | | |
Financial Times Media, Newspaper Publishing | Financial Times Media, Newspaper Publishing | Other 30 Nov 2022 | | |
Comcast Telecoms, Telecommunications | Comcast Telecoms, Telecommunications | Other 30 Nov 2022 | | |
Apple Consumer Electronics, Computers and Electronics Manufacturing | Apple Consumer Electronics, Computers and Electronics Manufacturing | Other 30 Nov 2022 | |